Elanco Animal Health Inc Share Price Today: Live Updates & Key Insights

Elanco Animal Health Inc share price today is $24.3, up -4.54%. The stock opened at $24.78 against the previous close of $25.12, with an intraday high of $24.9 and low of $23.77.

Elanco Animal Health Inc Share Price Chart

Elanco Animal Health Inc

us-stock
To Invest in {{usstockname}}
us-stock

Elanco Animal Health Inc Share Price Performance

$24.3 -0.0454(-4.54%) ELAN at 23 Mar 2026 12:51 PM Drug Manufacturers - Specialty & Generic
Lowest Today 23.77
Highest Today 24.9
Today’s Open 24.78
Prev. Close 25.12
52 Week High 27.72
52 Week Low 8.02
Day’s Range: Low 23.77 High 24.9
52-Week Range: Low 8.02 High 27.72
1 day return -
1 Week return +2.52
1 month return -3.11
3 month return +7.55
6 month return +25.94
1 year return +125.16
3 year return +163.51
5 year return -19.47
10 year return -

Elanco Animal Health Inc Institutional Holdings

Dodge & Cox 15.91

Blackstone Private Credit I 15.09

Dodge & Cox Stock I 10.69

FMR Inc 10.50

Vanguard Group Inc 9.67

PRIMECAP Management Company 9.30

BlackRock Inc 9.29

T. Rowe Price Investment Management,Inc. 6.34

Dimensional Fund Advisors, Inc. 5.05

Vanguard PRIMECAP Inv 3.59

UBS Group AG 3.31

iShares Core S&P Mid-Cap ETF 3.23

Vanguard Total Stock Mkt Idx Inv 3.16

State Street Corp 3.07

Vanguard Small Cap Index 2.26

Black Creek Investment Management Inc 2.22

Vanguard Capital Opportunity Inv 2.07

Morgan Stanley - Brokerage Accounts 2.06

Geode Capital Management, LLC 1.90

T. Rowe Price Mid-Cap Growth 1.82

Strategic Advisers Fidelity US TtlStk 1.72

Millennium Management LLC 1.63

T. Rowe Price US Mid-Cap Growth Equity 1.60

Fidelity Low-Priced Stock 1.57

Manufacturers Life Insurance Co 1.46

Vanguard Small Cap Value Index Inv 1.45

CI Global Leaders Fund D 1.45

Vanguard PRIMECAP Core Inv 1.45

DFA US Small Cap Value I 1.32

Nuveen, LLC 1.23

ClearBridge Advisors, LLC 1.19

Vanguard Institutional Extnd Mkt Idx Tr 1.08

Dodge & Cox Balanced Composite 1.07

Dodge & Cox Balanced I 1.07

Bank of New York Mellon Corp 1.03

Fuller & Thaler Asset Management Inc 1.00

T. Rowe Price US Small-Cap Core Equity 0.92

Fidelity VIP Mid Cap Initial 0.91

Barrow Hanley Mewhinney & Strauss LLC 0.87

Northern Trust Corp 0.86

Elanco Animal Health Inc Market Status

Strong Buy: 6

Buy: 1

Hold: 8

Sell: 0

Strong Sell: 0

Elanco Animal Health Inc Fundamentals

Market Cap 11922.09 M

PB Ratio 1.9076

PE Ratio 0.0

Enterprise Value 15394.09 M

Total Assets 13358.00 M

Volume 9322832

Elanco Animal Health Inc Company Financials

Annual Revenue FY25:4715000000 4715.0M, FY24:4439000000 4439.0M, FY23:4367000000 4367.0M, FY22:4418000000 4418.0M, FY21:4765000000 4765.0M

Annual Profit FY25:2050000000 2050.0M, FY24:1909000000 1909.0M, FY23:2504000000 2504.0M, FY22:2505000000 2505.0M, FY21:2631000000 2631.0M

Annual Net worth FY25:-232000000 -232.0M, FY24:338000000 338.0M, FY23:-1144000000 -1144.0M, FY22:-74000000 -74.0M, FY21:-472000000 -472.0M

Quarterly Revenue Q4/2025:1144000000 1144.0M, Q3/2025:1137000000 1137.0M, Q2/2025:1241000000 1241.0M, Q1/2025:1193000000 1193.0M, Q4/2024:1020000000 1020.0M

Quarterly Profit Q4/2025:450000000 450.0M, Q3/2025:607000000 607.0M, Q2/2025:577000000 577.0M, Q1/2025:556000000 556.0M, Q4/2024:389000000 389.0M

Quarterly Net worth Q4/2025:-276000000 -276.0M, Q3/2025:-34000000 -34.0M, Q2/2025:11000000 11.0M, Q1/2025:67000000 67.0M, Q4/2024:-8000000 -8.0M

About Elanco Animal Health Inc & investment objective

Company Information Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. The company offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Credelio Family, Interceptor Plus, Drontal family, and Drontal Plus; vaccines portfolio that provides differentiated prevention coverage for a number of important pet health risks; and therapeutics portfolio for the treatment of pain, otitis, cardiovascular, and dermatology indications, as well as osteoarthritis for dogs and cats under the Galliprant trademark. It also provides farm animal products that help farmers improve animal health and wellbeing, and raise livestock, such as cattle, swine, and poultry. In addition, the company offers medicated feed additives, injectable antibiotics, vaccines, insecticides and enzymes, and others under the Rumensin, Baytril, and Experior trademarks for cattle; and under the Maxiban and Monteban trademarks for the control and prevention of intestinal disease in poultry. Further, it offers other pet health products for cats and dogs under the Atopica, Milbemax, Onsior, and Tru Family trademarks; and other farm animal products for poultry, cattle, and swine under the AviPro, Catosal, Denagard, Hemicell, Pulmotil, and Surmax tradmarks. The company sells its products to third-party distributors and independent retailers; and directly to farm animal producers and veterinarians. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Indianapolis, Indiana.

Organisation Drug Manufacturers - Specialty & Generic

Employees 9400

Industry Drug Manufacturers - Specialty & Generic

CEO Mr. Jeffrey N. Simmons

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Elanco Animal Health Inc FAQs

What is the share price of Elanco Animal Health Inc today?

The current share price of Elanco Animal Health Inc is $24.3.

Can I buy Elanco Animal Health Inc shares in India?

Yes, Indian investors can buy Elanco Animal Health Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Elanco Animal Health Inc shares in India?

You can easily invest in Elanco Animal Health Inc shares from India by:

Can I buy fractional shares of Elanco Animal Health Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Elanco Animal Health Inc?

Elanco Animal Health Inc has a market cap of $11922.09 M.

In which sector does Elanco Animal Health Inc belong?

Elanco Animal Health Inc operates in the Drug Manufacturers - Specialty & Generic sector.

What documents are required to invest in Elanco Animal Health Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Elanco Animal Health Inc?

The PE ratio of Elanco Animal Health Inc is N/A and the PB ratio is 1.91.